These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 25221388)
21. 3-Hydroxy kynurenine treatment controls T. cruzi replication and the inflammatory pathology preventing the clinical symptoms of chronic Chagas disease. Knubel CP; Martínez FF; Acosta Rodríguez EV; Altamirano A; Rivarola HW; Diaz Luján C; Fretes RE; Cervi L; Motrán CC PLoS One; 2011; 6(10):e26550. PubMed ID: 22028903 [TBL] [Abstract][Full Text] [Related]
22. Differences in resistance to reinfection with low and high inocula of Trypanosoma cruzi in chagasic mice treated with nifurtimox and relation to immune response. Cabeza Meckert P; Chambó JG; Laguens RP Antimicrob Agents Chemother; 1988 Feb; 32(2):241-5. PubMed ID: 3129986 [TBL] [Abstract][Full Text] [Related]
24. Priming astrocytes with TNF enhances their susceptibility to Trypanosoma cruzi infection and creates a self-sustaining inflammatory milieu. Silva AA; Silva RR; Gibaldi D; Mariante RM; Dos Santos JB; Pereira IR; Moreira OC; Lannes-Vieira J J Neuroinflammation; 2017 Sep; 14(1):182. PubMed ID: 28877735 [TBL] [Abstract][Full Text] [Related]
25. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi. Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419 [TBL] [Abstract][Full Text] [Related]
26. Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic Rats. Wen JJ; Gupta S; Guan Z; Dhiman M; Condon D; Lui C; Garg NJ J Am Coll Cardiol; 2010 Jun; 55(22):2499-508. PubMed ID: 20510218 [TBL] [Abstract][Full Text] [Related]
27. Cholinergic Stimulation by Pyridostigmine Bromide Before Myocardial Infarction Prevent Cardiac and Autonomic Dysfunction. Barboza CA; Fukushima AR; Carrozzi N; Machi JF; Dourado PMM; Mostarda CT; Irigoyen MC; Nathanson L; Morris M; Caperuto EC; Rodrigues B Sci Rep; 2019 Feb; 9(1):2481. PubMed ID: 30792425 [TBL] [Abstract][Full Text] [Related]
28. Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease. de Paula Costa G; Silva RR; Pedrosa MC; Pinho V; de Lima WG; Teixeira MM; Bahia MT; Talvani A Parasite Immunol; 2010 Mar; 32(3):202-8. PubMed ID: 20398183 [TBL] [Abstract][Full Text] [Related]
29. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay. Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302 [TBL] [Abstract][Full Text] [Related]
30. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain. Cevey ÁC; Mirkin GA; Penas FN; Goren NB Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474 [TBL] [Abstract][Full Text] [Related]
31. A heart-specific CD4+ T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi. Ribeiro-Dos-Santos R; Mengel JO; Postol E; Soares RA; Ferreira-Fernandez E; Soares MB; Pontes-De-Carvalho LC Parasite Immunol; 2001 Feb; 23(2):93-101. PubMed ID: 11240900 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of TGF-β pathway reverts extracellular matrix remodeling in T. cruzi-infected cardiac spheroids. M Ferrão P; M Nisimura L; C Moreira O; G Land M; Pereira MC; de Mendonça-Lima L; C Araujo-Jorge T; C Waghabi M; R Garzoni L Exp Cell Res; 2018 Jan; 362(2):260-267. PubMed ID: 29208458 [TBL] [Abstract][Full Text] [Related]
33. Differential expression of systemic cytokine profiles in Chagas' disease is associated with endemicity of Trypanosoma cruzi infections. Samudio M; Montenegro-James S; de Cabral M; Martinez J; Rojas de Arias A; Woroniecky O; James MA Acta Trop; 1998 May; 69(2):89-97. PubMed ID: 9588229 [TBL] [Abstract][Full Text] [Related]
36. Correlation between intestinal BMP2, IFNγ, and neural death in experimental infection with Trypanosoma cruzi. do Carmo Neto JR; Vinicius da Silva M; Braga YLL; Florencio da Costa AW; Fonseca SG; Nagib PRA; Nunes Celes MR; Oliveira MAP; Machado JR PLoS One; 2021; 16(2):e0246692. PubMed ID: 33561140 [TBL] [Abstract][Full Text] [Related]
37. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions. Caldas IS; Talvani A; Caldas S; Carneiro CM; de Lana M; da Matta Guedes PM; Bahia MT Parasitol Res; 2008 Jul; 103(2):413-21. PubMed ID: 18454349 [TBL] [Abstract][Full Text] [Related]
38. Levels of anti-B13 antibodies over time in a cohort of chronic infected by Trypanosoma cruzi. Its relationship with specific treatment and clinical status. Olivera V; Bizai ML; Arias E; Suasnabar S; Bottasso O; Marcipar I; Fabbro D Acta Trop; 2021 Jun; 218():105908. PubMed ID: 33789152 [TBL] [Abstract][Full Text] [Related]
39. Potential Role of Carvedilol in the Cardiac Immune Response Induced by Experimental Infection with Horta AL; Leite AL; Paula Costa G; Figueiredo VP; Talvani A Biomed Res Int; 2017; 2017():9205062. PubMed ID: 28377930 [No Abstract] [Full Text] [Related]
40. Proteome expression and carbonylation changes during Trypanosoma cruzi infection and Chagas disease in rats. Wen JJ; Garg NJ Mol Cell Proteomics; 2012 Apr; 11(4):M111.010918. PubMed ID: 22199233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]